Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill

Mayo Clinic

Status: Completed

Conditions: Critical Illness; Sepsis

Study type: Observational

Funder types: Other

Identifiers

NCT04755777

20-007528

Details and patient eligibility

About

The purpose of the study is to characterize various healthcare practitioners' perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice.

Enrollment: 138 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Providers involved with beta-lactam TDM for critically ill patients

Exclusion criteria

• None